These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12135806)

  • 21. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disorders of fatty acid oxidation.
    Tein I
    Handb Clin Neurol; 2013; 113():1675-88. PubMed ID: 23622388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing face of disorders of fatty acid oxidation.
    Vockley J
    Mayo Clin Proc; 1994 Mar; 69(3):249-57. PubMed ID: 8133663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mitochondrial beta-oxidation defects].
    Woldseth B; Rootwelt T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):756-9. PubMed ID: 16541168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.
    Yusupov R; Finegold DN; Naylor EW; Sahai I; Waisbren S; Levy HL
    Mol Genet Metab; 2010 Sep; 101(1):33-9. PubMed ID: 20580581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.
    Okun JG; Kölker S; Schulze A; Kohlmüller D; Olgemöller K; Lindner M; Hoffmann GF; Wanders RJ; Mayatepek E
    Biochim Biophys Acta; 2002 Oct; 1584(2-3):91-8. PubMed ID: 12385891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple screening test for fatty acid oxidation defects using whole-blood palmitate oxidation.
    Seargeant LE; Balachandra K; Mallory C; Dilling LA; Greenberg CR
    J Inherit Metab Dis; 1999 Aug; 22(6):740-6. PubMed ID: 10472534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
    Kang E; Kim YM; Kang M; Heo SH; Kim GH; Choi IH; Choi JH; Yoo HW; Lee BH
    BMC Pediatr; 2018 Mar; 18(1):103. PubMed ID: 29519241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to triheptanoin therapy in critically ill patients with LC-FAOD: Report of patients treated through an expanded access program.
    Vockley J; Enns GM; Ramirez AN; Bedrosian CL; Reineking B; Lu X; Ray K; Rahman S; Marsden D
    Mol Genet Metab; 2022 Jun; 136(2):152-162. PubMed ID: 35459555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective ESI-MS/MS analysis of newborn blood spots from 18 symptomatic patients with organic acid and fatty acid oxidation disorders diagnosed either in infancy or in childhood.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Inherit Metab Dis; 2007 Aug; 30(4):606. PubMed ID: 17641825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective newborn screening of inborn errors of amino acids, organic acids and fatty acids metabolism in the Kingdom of Bahrain.
    Golbahar J; Al-Jishi EA; Altayab DD; Carreon E; Bakhiet M; Alkhayyat H
    Mol Genet Metab; 2013; 110(1-2):98-101. PubMed ID: 23916421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of normal acylcarnitine levels in a healthy pediatric population as a diagnostic tool in inherited errors of mitochondrial fatty acid beta-oxidation].
    Osorio JH; Pourfarzam M
    An Pediatr (Barc); 2007 Dec; 67(6):548-52. PubMed ID: 18053519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
    Vockley J; Marsden D; McCracken E; DeWard S; Barone A; Hsu K; Kakkis E
    Mol Genet Metab; 2015; 116(1-2):53-60. PubMed ID: 26116311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New developments in the pathophysiology, clinical spectrum, and diagnosis of disorders of fatty acid oxidation.
    Treem WR
    Curr Opin Pediatr; 2000 Oct; 12(5):463-8. PubMed ID: 11021412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficiency of the pyruvate dehydrogenase complex and of mitochondrial fatty acid oxidation.
    Bindoff LA; Birch-Machin MA; Jackson S; Singh Kler R; Bartlett K; Turnbull DM
    Rev Neurol (Paris); 1991; 147(6-7):526-31. PubMed ID: 1962058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatment.
    Vockley J; Burton B; Berry GT; Longo N; Phillips J; Sanchez-Valle A; Tanpaiboon P; Grunewald S; Murphy E; Humphrey R; Mayhew J; Bowden A; Zhang L; Cataldo J; Marsden DL; Kakkis E
    Mol Genet Metab; 2017 Apr; 120(4):370-377. PubMed ID: 28189603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders].
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Zhang YJ; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):692-5. PubMed ID: 18067086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation.
    Schaefer J; Pourfarzam M; Bartlett K; Jackson S; Turnbull DM
    Pediatr Res; 1995 Mar; 37(3):354-60. PubMed ID: 7784145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of mitochondrial fatty acid β-oxidation in human: what can we learn from inborn fatty acid β-oxidation deficiencies?
    Bastin J
    Biochimie; 2014 Jan; 96():113-20. PubMed ID: 23764392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.